<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Radioimmunological assays of peptidic hormone levels is now an essential procedure for the diagnosis of polyadenomatosis </plain></SENT>
<SENT sid="1" pm="."><plain>The diversity of pathological associations found in polyadenomatosis cannot be completely explained by the unitary theories that have been proposed </plain></SENT>
<SENT sid="2" pm="."><plain>Neither the APUD system, nor the common embryonic origin, nor the reduction in calcitonin excretion can fully explain the clinical picture: a logical explanation has still to be discovered </plain></SENT>
<SENT sid="3" pm="."><plain>In practice, ectopic secretions are frequent in type 2 polyadenomatosis (medullary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, <z:hpo ids='HP_0002666'>pheochromocytoma</z:hpo>, <z:mpath ids='MPATH_435'>neurofibroma</z:mpath>, <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e>, <z:hpo ids='HP_0000843'>hyperparathyroidism</z:hpo>) contrary to what is observed in type 1 cases (pituitary, parathyroid, pancreas) </plain></SENT>
</text></document>